Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-09 Sale | 2026-06-11 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 20,918 | $6.1615 | $128,886 | 2,389,420 (Direct) | View |
| 2026-06-04 Sale | 2026-06-08 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 34,976 | $6.2489 | $218,561 | 2,440,239 (Direct) | View |
| 2026-05-22 Sale | 2026-05-27 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 7,500 | $6.0907 | $45,680 | 2,498,790 (Direct) | View |
| 2026-05-20 Sale | 2026-05-22 6:19 pm | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 22,220 | $6.15 | $136,653 | 2,522,610 (Direct) | View |
| 2026-05-18 Sale | 2026-05-20 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 9,320 | $6.3754 | $59,418 | 2,563,350 (Direct) | View |
| 2026-05-14 Sale | 2026-05-18 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 28,680 | $6.7912 | $194,773 | 2,585,970 (Direct) | View |
| 2026-05-05 Sale | 2026-05-07 9:58 pm | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Chief Executive Officer | 10,315 | $8.0395 | $82,927 | 2,565,226 (Indirect) | View |
| 2025-05-27 Sale | 2025-05-29 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 2,558 | $10.23 | $26,179 | 2,806,084 (Indirect) | View |
| 2025-05-22 Sale | 2025-05-27 4:02 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 2,182 | $10.91 | $23,804 | 2,808,642 (Indirect) | View |
| 2025-05-20 Sale | 2025-05-22 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.04 | $44,160 | 2,810,824 (Indirect) | View |
| 2025-05-16 Sale | 2025-05-20 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.21 | $44,840 | 2,814,824 (Indirect) | View |
| 2025-05-14 Sale | 2025-05-16 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 2,020 | $10.69 | $21,586 | 2,818,824 (Indirect) | View |
| 2025-05-12 Sale | 2025-05-14 4:04 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.96 | $43,860 | 2,820,844 (Indirect) | View |
| 2025-03-21 Sale | 2025-03-25 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 174 | $10 | $1,740 | 2,824,844 (Indirect) | View |
| 2025-03-19 Sale | 2025-03-21 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.11 | $40,440 | 2,825,018 (Indirect) | View |
| 2025-03-17 Sale | 2025-03-19 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 2,242 | $11.89 | $26,658 | 2,829,018 (Indirect) | View |
| 2025-03-13 Sale | 2025-03-17 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $12.05 | $48,220 | 2,831,260 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-09 Exercise | 2026-06-11 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 20,918 | $0.75 | 2,389,420 (Direct) | View |
| 2026-06-09 Exercise | 2026-06-11 4:01 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 20,918 | $0 | 2,389,420 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:13 pm | N/A 2036-06-08 | GYRE THERAPEUTICS INC. | GYRE | Bergmann Joshua Benjamin GC and Corporate Secretary | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:13 pm | N/A 2036-06-08 | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Chief Executive Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-06-04 Exercise | 2026-06-08 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 34,976 | $0.75 | 2,440,239 (Direct) | View |
| 2026-06-04 Exercise | 2026-06-08 4:01 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 34,976 | $0 | 2,440,239 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 7,500 | $0.75 | 2,498,790 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 4:01 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 7,500 | $0 | 2,498,790 (Direct) | View |
| 2026-05-20 Exercise | 2026-05-22 6:19 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 22,220 | $0.75 | 2,522,610 (Direct) | View |
| 2026-05-20 Exercise | 2026-05-22 6:19 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 22,220 | $0 | 2,522,610 (Direct) | View |
| 2026-05-18 Exercise | 2026-05-20 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 9,320 | $0.75 | 2,563,350 (Direct) | View |
| 2026-05-18 Exercise | 2026-05-20 4:01 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 9,320 | $0 | 2,563,350 (Direct) | View |
| 2026-05-14 Exercise | 2026-05-18 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 28,680 | $0.75 | 2,585,970 (Direct) | View |
| 2026-05-14 Exercise | 2026-05-18 4:01 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 28,680 | $0 | 2,585,970 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A 2036-02-27 | GYRE THERAPEUTICS INC. | GYRE | Bergmann Joshua Benjamin GC and Corporate Secretary | 0 | $0 | 47,530 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A 2028-06-07 | GYRE THERAPEUTICS INC. | GYRE | Wang Jialiang (NMN) EVP, General Manager | 0 | $0 | 223,391 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Xiong Yue Chief Scientific Officer | 0 | $0 | 2,376,500 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Chief Executive Officer | 0 | $0 | 10,353,532 (Indirect) | View |
| 2026-05-04 Other | 2026-05-06 8:40 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | GNI Group Ltd. GNI USA Inc. 10% Owner | 2,601,826 | $0 | 2,601,826 (Indirect) | View |
| 2026-05-04 Option Award | 2026-05-06 8:38 pm | N/A 2028-06-07 | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Chief Financial Officer | 408,757 | $0 | 408,757 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-09 4:01 pm | N/A 2036-01-07 | GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-01-07 Option Award | 2026-01-09 4:01 pm | N/A 2036-01-07 | GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-08-18 Option Award | 2025-08-26 4:09 pm | N/A 2035-08-18 | GYRE THERAPEUTICS INC. | GYRE | Weng Dan Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2025-08-05 Option Award | 2025-08-07 8:00 pm | N/A 2035-08-05 | GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:22 pm | N/A 2035-06-04 | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:22 pm | N/A 2035-06-04 | GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:22 pm | N/A 2035-06-04 | GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:22 pm | N/A 2035-06-04 | GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:22 pm | N/A 2035-06-04 | GYRE THERAPEUTICS INC. | GYRE | Carmichael Gordon Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2025-05-27 Option Award | 2025-05-28 6:13 pm | N/A 2035-05-27 | GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2025-04-01 Exercise | 2025-05-14 8:21 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 50,000 | $0.75 | 1,665,115 (Direct) | View |
| 2025-04-01 Exercise | 2025-05-14 8:21 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 50,000 | $0 | 1,665,115 (Direct) | View |
| 2025-03-24 Exercise | 2025-04-25 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 650,000 | $0.75 | 4,195,345 (Direct) | View |
| 2025-03-24 Exercise | 2025-04-25 4:01 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 650,000 | $0 | 4,195,345 (Direct) | View |
| 2025-04-16 Exercise | 2025-04-18 5:27 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director | 15,000 | $6.93 | 314,652 (Direct) | View |
| 2025-04-16 Exercise | 2025-04-18 5:27 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director | 15,000 | $0 | 314,652 (Direct) | View |